– Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – – EU...
Vous n'êtes pas connecté
– Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – – EU...
COPENHAGEN, Denmark; June 27, 2024 – Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Truist's (TFC) board of directors has approved a share repurchase authorization worth $5 billion through 2026, following the clearance of the 2024...
Truist's (TFC) board of directors has approved a share repurchase authorization worth $5 billion through 2026, following the clearance of the 2024...
STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused...
EG 427, a biotechnology company leading the development of pinpoint DNA medicines for prevalent diseases in neurology based on its unique...
Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and...
Over the past 12 years, computer and video game distribution strategies have undergone a seismic shift. Sales of digital games exceeded those of...